JAFL
BCYC

Jay A. Fishman Ltd’s Bicycle Therapeutics BCYC Stock Holding History

Jay A. Fishman Ltd’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,000
Closed -$224K – 87
2024
Q1 		$224K Sell
9,000
-25,500
-74% -$542K 0.02% 85
2023
Q4 		$624K Sell
34,500
-3,000
-8% -$49.6K 0.07% 60
2023
Q3 		$753K Buy
37,500
+17,000
+83% +$389K 0.1% 51
2023
Q2 		$523K Buy
20,500
+10,000
+95% +$232K 0.06% 67
2023
Q1 		$223K Hold
10,500
– – 0.03% 88
2022
Q4 		$311K Buy
+10,500
New +$282K 0.04% 77

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Jay A. Fishman Ltd's BCYC Position: Q2 2024 in Review

Jay A. Fishman Ltd sold out of Bicycle Therapeutics (BCYC) in Q2 2024, closing a stake of 9,000 shares — an estimated $224K sold.

Jay A. Fishman Ltd first reported a position in BCYC in Q4 2022 and held it in 6 quarters. The position peaked at $753K in Q3 2023. 107 funds tracked by Wall St. Rank hold BCYC as of Q2 2024.

  • Jay A. Fishman Ltd reported no remaining Bicycle Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Jay A. Fishman Ltd sold 9,000 Bicycle Therapeutics shares in Q2 2024, an estimated $224K.
  • Jay A. Fishman Ltd first reported a position in Bicycle Therapeutics in Q4 2022 and held it in 6 quarters.
  • Jay A. Fishman Ltd's Bicycle Therapeutics position peaked at $753K in Q3 2023.
  • 107 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2024.

Based on Jay A. Fishman Ltd's 13F filing for Q2 2024, filed 31 Jul 2024.